• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RSPO4-CRISPR 减轻肝纤维化大鼠模型的肝损伤并恢复肠道微生物群。

RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis.

机构信息

Center for Gastroenterology and Hepatology, Institute of Liver Diseases, The Affiliated Hospital of Jiaxing College, Jiaxing, Zhejiang Province, PR China.

Department of Basic Medicine Sciences, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, PR China.

出版信息

Commun Biol. 2021 Feb 18;4(1):230. doi: 10.1038/s42003-021-01747-5.

DOI:10.1038/s42003-021-01747-5
PMID:33603089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893072/
Abstract

Wnt signaling dysfunction and gut dysbiosis may lead to liver fibrosis, yet the underlying mechanisms are not well elucidated. This study demonstrated the role of RSPO4, a Wnt signaling agonist, in liver fibrogenesis and its impact on the gut microbiome. RSPO4 gene in CCl-induced fibrotic-liver rats was knockout by Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system, with healthy rats served as the control. Tissue samples and hepatic stellate cells (HSCs) isolated from rats were examined for curative effect of RSPO4-CRISPR treatment. Fecal sample were collected and analyzed with 16 S rRNA sequencing. We found RSPO4-CRISPR relieved liver fibrosis in rats and reversed HSC activation. Further, results showed RSPO4-CRISPR tended to restore the microflora composition. Significance species between groups were identified. Bacteroides and Escherichia-Shigella were the key microbes in the model and negative group, whereas Lactobacillus, Romboutsia, and Lachnospiraceae NK4A136 group were abundant in the control. Notably, Bacteroidales S24-7 group and Ruminococcaceae UCG-005 were the significantly enriched in CRISPR group. We show that the microbiome of rats treated with RSPO4-CRISPR presents a trend towards the restoration of the original condition. Our findings pave a new way to evaluate the curative effect of liver fibrosis treatment.

摘要

Wnt 信号功能障碍和肠道菌群失调可能导致肝纤维化,但潜在机制尚不清楚。本研究表明 Wnt 信号激动剂 RSPO4 在肝纤维化发生中的作用及其对肠道微生物组的影响。采用 Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR)系统敲除 CCl4 诱导的纤维化肝脏大鼠的 RSPO4 基因,健康大鼠作为对照。检测 RSPO4-CRISPR 治疗对大鼠的疗效,对组织样本和分离的肝星状细胞(HSCs)进行检查。收集粪便样本并进行 16S rRNA 测序分析。我们发现 RSPO4-CRISPR 可缓解大鼠肝纤维化并逆转 HSC 激活。此外,结果表明 RSPO4-CRISPR 倾向于恢复微生物群落组成。鉴定了组间的重要物种。拟杆菌属和埃希氏菌-志贺氏菌属是模型和阴性组中的关键微生物,而乳杆菌属、罗姆布氏菌属和lachnospiraceae NK4A136 属在对照组中丰富。值得注意的是,Bacteroidales S24-7 组和 Ruminococcaceae UCG-005 在 CRISPR 组中明显富集。我们表明,用 RSPO4-CRISPR 治疗的大鼠的微生物组呈现出恢复原始状态的趋势。我们的发现为评估肝纤维化治疗的疗效开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/912d4b508718/42003_2021_1747_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/e7d2b1767e4c/42003_2021_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/42d4743a3682/42003_2021_1747_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/20975581fb16/42003_2021_1747_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/8c230de77dd1/42003_2021_1747_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/99c721f8cd1a/42003_2021_1747_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/f6f62942cad1/42003_2021_1747_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/912d4b508718/42003_2021_1747_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/e7d2b1767e4c/42003_2021_1747_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/42d4743a3682/42003_2021_1747_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/20975581fb16/42003_2021_1747_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/8c230de77dd1/42003_2021_1747_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/99c721f8cd1a/42003_2021_1747_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/f6f62942cad1/42003_2021_1747_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d2/7893072/912d4b508718/42003_2021_1747_Fig7_HTML.jpg

相似文献

1
RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis.RSPO4-CRISPR 减轻肝纤维化大鼠模型的肝损伤并恢复肠道微生物群。
Commun Biol. 2021 Feb 18;4(1):230. doi: 10.1038/s42003-021-01747-5.
2
Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.在大鼠模型中,LRP6基因编辑技术预防酒精性肝损伤的有益效果超过了粪便微生物群移植。
Gut Microbes. 2020 Jul 3;11(4):1015-1029. doi: 10.1080/19490976.2020.1736457. Epub 2020 Mar 13.
3
Role of growth factor receptor-bound 2 in CCl-induced hepatic fibrosis.生长因子受体结合蛋白2在四氯化碳诱导的肝纤维化中的作用。
Biomed Pharmacother. 2017 Aug;92:942-951. doi: 10.1016/j.biopha.2017.05.142. Epub 2017 Jun 10.
4
A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.一个长链非编码 RNA Gpr137b-ps/miR-200a-3p/CXCL14 轴调节肝星状细胞 (HSC) 激活。
Toxicol Lett. 2021 Jan 1;336:21-31. doi: 10.1016/j.toxlet.2020.10.001. Epub 2020 Oct 15.
5
ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.ECM1 可防止转化生长因子 β 在小鼠中被激活、肝星状细胞活化以及纤维化形成。
Gastroenterology. 2019 Nov;157(5):1352-1367.e13. doi: 10.1053/j.gastro.2019.07.036. Epub 2019 Jul 27.
6
Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.肌球蛋白结合转录因子 A 与肌球蛋白相关转录因子 A 协同介导肌动蛋白细胞骨架依赖性的肝纤维化抑制。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G504-G517. doi: 10.1152/ajpgi.00302.2019. Epub 2020 Jan 13.
7
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.青蒿琥酯补充剂对肝硬化大鼠肠道细菌易位和肠道微生物群失调的影响。
World J Gastroenterol. 2016 Mar 14;22(10):2949-59. doi: 10.3748/wjg.v22.i10.2949.
8
Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.镁甘氨酸甘草酸盐通过调节铁死亡信号通路改善肝纤维化和肝星状细胞激活。
Biomed Pharmacother. 2018 Oct;106:125-133. doi: 10.1016/j.biopha.2018.06.060. Epub 2018 Jun 26.
9
Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.罗格列酮通过上调 microRNA-124-3p 抑制肝星状细胞活化缓解肝纤维化。
Dig Dis Sci. 2019 Jun;64(6):1560-1570. doi: 10.1007/s10620-019-5462-8. Epub 2019 Jan 23.
10
Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.甘草酸抑制四氯化碳诱导的大鼠肝损伤中的细胞凋亡和纤维化。
World J Gastroenterol. 2015 May 7;21(17):5271-80. doi: 10.3748/wjg.v21.i17.5271.

引用本文的文献

1
Cardiac Fibroblasts: Helping or Hurting.心脏成纤维细胞:助力还是伤害?
Genes (Basel). 2025 Mar 27;16(4):381. doi: 10.3390/genes16040381.
2
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.多组学揭示微生物代谢产物是克罗恩病肠道纤维化的关键因素。
EMBO Mol Med. 2024 Oct;16(10):2427-2449. doi: 10.1038/s44321-024-00129-8. Epub 2024 Sep 13.
3
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis.

本文引用的文献

1
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.粪便微生物胶囊在肝性脑病中是安全的:一项 1 期、随机、安慰剂对照试验。
Hepatology. 2019 Nov;70(5):1690-1703. doi: 10.1002/hep.30690. Epub 2019 Jun 18.
2
species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota.这些物种通过调节免疫反应和改变肠道微生物群来改善葡聚糖硫酸钠诱导的结肠炎。
Gut Microbes. 2019;10(6):696-711. doi: 10.1080/19490976.2019.1589281. Epub 2019 Apr 3.
3
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).
整合粪便代谢组学和肠道微生物群以研究大麻二酚治疗特发性肺纤维化的机制。
Front Pharmacol. 2024 Feb 6;15:1358626. doi: 10.3389/fphar.2024.1358626. eCollection 2024.
4
Gut microbiota and metabolites in estrus cycle and their changes in a menopausal transition rat model with typical neuroendocrine aging.发情周期中肠道微生物群和代谢物及其在具有典型神经内分泌衰老的更年期过渡大鼠模型中的变化。
Front Endocrinol (Lausanne). 2023 Dec 15;14:1282694. doi: 10.3389/fendo.2023.1282694. eCollection 2023.
5
Characterization of Gut Microbiota Compositions along the Intestinal Tract in Double Knockout Piglets and Their Potential Roles in Iron Absorption.肠道微生物群落组成沿肠道在双敲除仔猪及其在铁吸收中的潜在作用的表征。
Microbiol Spectr. 2023 Feb 14;11(1):e0190622. doi: 10.1128/spectrum.01906-22. Epub 2023 Jan 10.
6
Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction.心肌梗死后心脏纤维化治疗的新疗法
Biomedicines. 2022 Sep 2;10(9):2178. doi: 10.3390/biomedicines10092178.
7
The Roles and Mechanisms of lncRNAs in Liver Fibrosis.长链非编码RNA在肝纤维化中的作用及机制
Front Pharmacol. 2021 Nov 24;12:779606. doi: 10.3389/fphar.2021.779606. eCollection 2021.
8
Effects of novel flavonoid-enriched yogurt on the diversity of intestinal microbiota in mice.新型黄酮丰富酸奶对小鼠肠道微生物多样性的影响。
Braz J Microbiol. 2021 Dec;52(4):2287-2298. doi: 10.1007/s42770-021-00598-w. Epub 2021 Aug 27.
肠道微生物组与非酒精性脂肪性肝病(NAFLD)之间的联系。
Cell Mol Life Sci. 2019 Apr;76(8):1541-1558. doi: 10.1007/s00018-019-03011-w. Epub 2019 Jan 25.
4
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.志贺菌和肠产毒性大肠杆菌腹泻导致的发病和死亡:1990-2016 年全球疾病负担研究。
Lancet Infect Dis. 2018 Nov;18(11):1229-1240. doi: 10.1016/S1473-3099(18)30475-4. Epub 2018 Sep 25.
5
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.肠道微生物群介导的胆汁酸代谢通过 NKT 细胞调节肝癌。
Science. 2018 May 25;360(6391). doi: 10.1126/science.aan5931.
6
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
7
Protective Effect of against Immune-Mediated Liver Injury in a Mouse Model.在小鼠模型中[具体物质]对免疫介导性肝损伤的保护作用
Front Microbiol. 2017 Sep 26;8:1804. doi: 10.3389/fmicb.2017.01804. eCollection 2017.
8
Microbiota, cirrhosis, and the emerging oral-gut-liver axis.微生物群、肝硬化和新兴的口腔-肠道-肝脏轴。
JCI Insight. 2017 Oct 5;2(19):94416. doi: 10.1172/jci.insight.94416.
9
Intestinal Lactobacillus in health and disease, a driver or just along for the ride?肠道乳杆菌与健康和疾病:驱动因素还是仅仅是搭便车者?
Curr Opin Biotechnol. 2018 Feb;49:140-147. doi: 10.1016/j.copbio.2017.08.004. Epub 2017 Sep 1.
10
The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat.肝肠微生物轴调节他克林在大鼠中的肝毒性。
Hepatology. 2018 Jan;67(1):282-295. doi: 10.1002/hep.29327. Epub 2017 Nov 19.